Evidence map›Paper›PMID 30373212›Full record

ReviewMolecules (Basel, Switzerland)2018

Recent Advances in Indazole-Containing Derivatives: Synthesis and Biological Perspectives.

Shu-Guang Zhang, Chao-Gen Liang, Wei-Hua Zhang

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Indazole Derivatives Against Murine Cutaneous Leishmaniasis.Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Visible-Light-Driven Decarboxylative Coupling of 2The Journal of organic chemistry · 2024
    Article
  13. Article
  14. LiOMolecules (Basel, Switzerland) · 2023
    Article
  15. Review
  16. Study of the Addition Mechanism of 1The Journal of organic chemistry · 2022
    Article
  17. Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 MEuropean journal of medicinal chemistry reports · 2022
    Article
  18. Article
  19. Article
  20. Synthesis ofBeilstein journal of organic chemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shu-Guang ZhangJiangsu Key Laboratory of Pesticide Science, College of Sciences, Nanjing Agricultural University, Nanjing 210095, China. shuguangz@njau.edu.cn.ORCID 0000-0003-1333-3157
Chao-Gen LiangJiangsu Key Laboratory of Pesticide Science, College of Sciences, Nanjing Agricultural University, Nanjing 210095, China. 2016111015@njau.edu.cn.
Wei-Hua ZhangJiangsu Key Laboratory of Pesticide Science, College of Sciences, Nanjing Agricultural University, Nanjing 210095, China. njzhangwh@126.com.ORCID 0000-0003-1994-5306

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indazole-containing derivatives represent one of the most important heterocycles in drug molecules. Diversely substituted indazole derivatives bear a variety of functional groups and display versatile biological activities; hence, they have gained considerable attention in the field of medicinal chemistry. This review aims to summarize the recent advances in various methods for the synthesis of indazole derivatives. The current developments in the biological activities of indazole-based compounds are also presented.

Indexed as

Chemistry Techniques, SyntheticDrug DesignIndazolesStructure-Activity RelationshipIndazolesbiological activitiesindazolesynthesis

Identifiers

PMID30373212
PMCPMC6278422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.